Vol 6 (February 2019): Stem Cell Investigation

Review Article 
The past, present, and future of CRM1/XPO1 inhibitors
Amy Y. Wang, Hongtao Liu
Stem Cell Investigation  
2019
6:
6  
Editorial 
Personalized chemotherapy in triple-negative breast cancer: are we ready for prime time?
Romualdo Barroso-Sousa, Geoffrey I. Shapiro, Sara M. Tolaney
Stem Cell Investigation  
2019
6:
4  
Original Article 
Valproic acid simulates in vitro migration of the placenta-derived mesenchymal stem/stromal cell line CMSC29
Balta Al-Sowayan, Rosemary J. Keogh, Mohammed Abumaree, Harry M. Georgiou, Bill Kalionis
Stem Cell Investigation  
2019
6:
3